The Transformative Power of Bone Growth Concepts

The landscape of oral health is constantly shifting–fueled by stunning scientific breakthroughs that continue to accelerate at an extraordinary pace. One revolution that is making a mark these days is the ‘Bone Growth Concept.’ This innovation stands at the precipice of transforming dental care. However, before we delve into the specifics of this game-changing approach, let’s demystify what ‘Bone Growth Concept’ actually entails.
Bone Formation and Growth: A Dynamic Process

Casting a spotlight on human development, the crucial process of osteogenesis (i.e. bone formation), embarks on its fascinating journey mere weeks after conception. The intricate interplay of cartilage and connective tissues in an eight-week-old embryo paints a blueprint of a skeletal pattern. But the marvel doesn’t cease there–bone development progresses relentlessly, evolving even beyond our growth years, to mend fractures and adapt to shifting lifestyles. Stepping up to this challenging task are the linchpins of osteogenesis—osteoblasts, osteocytes, and osteoclasts. From constructing new bone to maintaining bone framework to breaking down bone tissue for remodeling and healing, this dynamic trio carries on a carefully choreographed dance in a sense.

A Cornerstone in Advanced Dentistry

Within the dentistry field, the ‘bone growth concept’ serves as a commanding blueprint for optimizing the dynamics of bone regeneration. It lays down not only the understanding of the principles governing bone growth but also pinpoints the innovative techniques and materials that further amplify bone healing. These techniques are particularly useful in high-stakes areas of the oral and maxillofacial region.

The success of intricate dental procedures such as dental implants, bone grafting, and periodontal surgeries hinges on this conceptual framework. By leveraging these insights, dentists and oral surgeons can deliver state-of-the-art treatments that dramatically improve their patients’ oral health and overall quality of life. Through the bone growth concept, they are able to engineer exceptional care that fits the unique needs of their patients’ bony structures, thus ensuring sustainable, long-term success in various dental procedures.

Proving its mettle in dental implant systems, the platform-switch has taken a leap forward with its evolution— the backtaper. This add-on element now provides an amplified space for both hard and soft tissues to establish a stronger union with the implant than what cylindrical and conical implant shapes offer. It’s essential to stress here that this isn’t just important—it’s critical for a successful dental implant–and subsequently for overall oral health.

Leveling Up with Subcrestal Positioning

Clinical expertise supports that the space created by the backtaper can be further expanded by positioning the copaSKY implant subcrestally. The thin, concave-shaped abutments (the connecting elements between the implants and the prosthesis) allow for more room for soft tissue attachment and bone growth on the backtaper.

The Miracle of Microstructured Surface 

Adding another feather in this concept’s cap is the microstructured surface of the backtaper–supporting robust attachments of bone and connective tissue. By situating the edge of the backtaper subcrestally, it becomes possible to deposit bone chips on it. What this does is reduce soft tissue ingrowth and provides another pillar of support for osseointegration—the process that essentially allows dental implants to become a part of the bone structure.

Impressive Clinical Outcomes

Clinicians are now convinced by the remarkable results—new bone formation is noticeable, from single-tooth restoration to extensive edentulous jaw rehabilitation based on SKY’s fast and fixed therapy procedures.

The Bone Growth Concept takes the platform-switch a step further—incorporating the implant and abutment design, the microstructured backtaper, and the subcrestal positioning of the copaSKY implants—it actively inhibits bone resorption and reliably backs the formation of new bone that fully wraps around the implant.

To quote Professor Jörg Neugebauer, president elect of Academy of Osseointegration, “For the Bone Growth Concept, we require platform switching implants with micro-structured shoulders, essential for osseointegration and a stable marginal bone level.” Further proving the power and potential this concept holds for the future of oral health.

Hot this week

Cartessa Aesthetics Partners with Classys to Bring EVERESSE to the U.S. Market

Classys, which is listed on the KOSDAQ, is one of South Korea's most distinguished aesthetic technology manufacturers, with devices distributed in 80+ markets globally. This partnership marks Classys's official entry into the American marketplace, with Cartessa Aesthetics as the exclusive distributor for EVERESSE, launched under the Volnewmer brand in current global markets.

Stryker Launches Next-Generation of SurgiCount+

Now integrated with Stryker's Triton technology, SurgiCount+ addresses two key challenges: retained surgical sponges and blood loss assessment. Integrating these previously separate digital solutions provides the added benefit of a more efficient, streamlined workflow for hospitals notes Stryker.

Nevro Receives CE Mark In Europe for It’s HFX iQ™ Spinal Cord Stimulation System

Nevro notes HFX iQ is the first and only SCS system with artificial intelligence (AI) technology that combines high-frequency (10 kHz) therapy built on landmark evidence that uses ongoing cloud data insights to deliver personalized pain relief

Recor Medical Reports: CMS Grants Distinct TPT Device Code and Category to Recor Medical for Ultrasound Renal Denervation

The approval of TPT offers incremental reimbursement payments for outpatient procedures performed with ultrasound renal denervation for Medicare fee-for-service beneficiaries. It becomes effective January 1, 2025, and is expected to remain effective for up to three years notes Recor Medical.

Jupiter Endovascular Reports | 1st U.S. Patient Treated with Jupiter Shape-shifting Thrombectomy Device

“Navigation challenges during endovascular procedures are often underappreciated and have led to under-adoption of life-saving procedures, such as pulmonary embolectomy. We have purpose-built our Endoportal Control technology to solve these issues and make important endovascular procedures accessible to more clinicians and their patients who can benefit from them,” said Carl J. St. Bernard, Jupiter Endovascular CEO. “This first case in the U.S. could not have gone better, and appears to validate the safety and performance we are seeing in our currently-enrolling European SPIRARE I study.”
Exit mobile version